Orkla's Volume Recovery Is Real — Until You Ask About Q4
The packaged-foods group delivered a strong volume-led quarter, but phasing, FX and a still-soft Food Ingredients unit mean the strategic reset waits for December's Capital Markets Day.
ORK.OL · Earnings Call · 2026-11-06
A good quarter with a conservative translation
Orkla's third quarter opened with the right numbers: “Organic growth was 3.1%, with a broad-based positive contribution from a majority of the portfolio companies.” — Nils Selte, President and CEO · 2026-11-06 Volume mix contributed 2.7%, underlying EBIT adjusted rose 8.1%, and adjusted EPS reached NOK 1.94, up 4.9%. Eight of nine consolidated portfolio companies improved underlying EBIT. After a second quarter in which management admitted it was “not happy with the overall growth on top line and volumes” — Arve Regland, Chief Financial Officer · 2026-08-20, this is a clear improvement. The organic revenue trajectory has flipped from decline to growth, and volume mix did most of the work.
But the caveat came in the Q&A. Asked to quantify the phasing benefit, CEO Nils Selte declined and anchored investors to the year-to-date number instead:
As you know, we don't guide for Q4. But what I said in the presentation was that if you look at the year-to-date numbers and the growth -- volume growth year-to-date, 1.5%, we think that that's kind of a correct underlying or view on the underlying performance of the business at the moment.
That is the key tension. The reported 2.7% volume mix is not the run-rate management wants investors to underwrite; the YTD 1.5% is. The difference is promotion timing, earlier Christmas sales in Snacks, an ERP comparison in Foods and positive phasing in Home & Personal Care. None of that is fake growth, but some of it is borrowed from Q4. Reported operating revenue also fell 2% because of negative currency translation effects of 6.4%, so the top-line optics are weaker than the underlying story.
The portfolio is not one story
Snacks was the star: organic growth of 5.6%, volume mix of 11% and EBIT up 16%, helped by Bubs in the U.S. and the Nordics, Smash! and a chocolate recovery. That recovery looks better against a depressed base; a year ago management was flagging “at least a 10% volume decline on -- due to chocolate price increases” — Arve Regland, Chief Financial Officer · 2025-11-14. Home & Personal Care also grew 10% organically, almost entirely volume, though part of that was phasing.
The weak spots are still weak. Jotun's underlying revenue rose 13%, but operating profit grew only 1.3% as raw material costs and margin pressure bit. Orkla's share of Jotun profit fell 6.6% to NOK 563 million. Selte said the pressure should continue: “we expect this picture to continue going forward. But the magnitude of it, it's very hard to give a precise answer on that.” — Nils Selte, President and CEO · 2026-11-06 Orkla Health had flat organic growth and another warning of weak profitability in coming quarters; the quarter also carried goodwill and trademark write-downs in Healthspan and a loss on the Eisunion sale. Food Ingredients — the company's top keyword this quarter — had organic growth of just 0.7% and underlying EBIT down 2%. The cost actions under acting CEO Marianne Kirkegaard will not show up this year and only gradually through 2027: “We don't expect to see anything this current year because this is longer processes. But you should see gradually effects throughout 2027 from these initiatives.” — Nils Selte, President and CEO · 2026-11-06 That is consistent with the prior call, when CFO Arve Regland said the mitigating actions would have “a bit longer term” — Arve Regland, Chief Financial Officer · 2026-08-20 impact, from next year and onwards.
India's 19% organic growth was mostly price, with volume up 2.9%, and a NOK 8 million government grant flattered EBIT; excluding it, growth was flat. European Pizza's consumer sales rose 9.7%, but organic revenue fell 1.9% on lower third-party wholesale sales at Kotipizza. So the broad-based claim is true at the EBIT line, but not evenly true at the quality-of-growth line.
Cash, costs and the December reset
Cash flow from operations was NOK 4.4 billion YTD, about NOK 400 million lower than last year. Half of the decline was working capital: higher receivables and a temporary inventory build ahead of an ERP implementation in Orkla Foods Norway. Arve put it plainly: “about half of the decline was due to working capital. And this reflects both a higher receivables following sales growth and a temporary inventory buildup ahead of an ERP implementation in Orkla Foods Norway.” — Arve Regland, CFO or similar financial executive (inferred from context) · 2026-11-06 That is timing, not demand, but it is a reminder that cash conversion can be noisy. Leverage was 2.1x EBITDA; Orkla bought back about NOK 1 billion of shares in the quarter and has a new NOK 4 billion program running.
The bigger event is December 1. Selte will use the Capital Markets Day to review the strategy period and set priorities and financial targets for the next four years. He has already conceded that return on capital employed, while improved, is short of the old goal: “The return on capital employed has improved significantly over the strategy period, but we do not expect to reach 13%.” — Nils Selte, President and CEO · 2026-11-06 Orkla says it is on track to finish 2026 in the mid-to-upper range of its 8% to 10% underlying EBIT growth target, and the EBIT margin is within range. But the market is being asked to wait for the new framework. The global keyword tape has Markets Day as a top-10 theme this quarter, and Orkla is about to give the market one. The global tape also has Food Ingredients among its top themes — a reminder that Orkla's problem child sits in a sector the market is watching.
What to watch
Three things: whether Q4 volume growth reverses the Q3 phasing benefit; whether Jotun's margin pressure peaks; and whether the CMD gives a credible path for Food Ingredients and Health. The quarter was good enough to buy management time. December is where they have to spend it.